Testing a new less invasive mitral valve replacement (SATURN)
Part of Heart & circulation clinical trials.
This trial tests a new, less invasive device called the SATURN system to replace a severely leaky mitral heart valve without open-heart surgery. It is for people who are too high-risk for traditional surgery and are willing to take blood thinners.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You have moderate to severe or severe mitral regurgitation (a leaky heart valve) that causes symptoms like shortness of breath or fatigue.
- You are considered high-risk for open-heart valve surgery by your heart team because of your age, other health problems, or frailty.
- You are able to take blood thinners (oral anticoagulation).
- You have not had prior mitral valve treatment (like a clip, repair, or replacement).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device called the Capstan system to fix a leaky mitral valve (mitral regurgitation) without open-heart surgery. It may help people whose valve leak is moderate to severe and still have symptoms despite medicines.
This study checks whether an innovative device can safely replace a damaged mitral valve in people who are higher risk for open-heart surgery. It looks at how well the procedure and follow-up work for improving mitral leakage symptoms.
This trial tests a new, less invasive heart valve (Sutra Hemi-valve) for people with a leaky mitral valve who cannot have standard surgery. The valve is delivered through a vein in your leg, so you avoid open-heart surgery.
This trial tests a new, less invasive replacement valve for people whose mitral heart valve is failing. The goal is to improve blood flow and reduce symptoms like shortness of breath without the need for major open-heart surgery.
This trial studies a new catheter-based valve replacement system for people with moderate to severe, or severe, mitral valve regurgitation (a leaky mitral valve). It aims to check whether the procedure is safe and can improve heart function compared with expected care.
This trial tests a new device to fix a leaky mitral valve in people with moderate to severe leakage who are too high-risk for open-heart surgery. It aims to improve heart function and symptoms.
Hear when a new Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.